Arkolith/Insider Trading/GALT/Form 4/A

Lewis Joel

President and CEO, DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4/A · filed Jan 22, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 16, 2026Grant(A)91K—$091K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001133416-26-000046) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML